Clinical Trial Update: A Clinical Study Investigating the Safety and Immune Responses After Immunization With Investigational Monkeypox Vaccines [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/2 trial of an investigational monkeypox vaccine by BioNTech completed, evaluating safety and immune responses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monkeypox

Drugs mentioned

• Investigational monkeypox vaccine

Snippet

Sponsor: BioNTech SE | Conditions: Monkeypox | Phase 1, Phase 2 | Status: COMPLETED